… Our previous work showed that fibroblast growth factor-2 induces … growth factor receptor
(FGFR) inhibitor PD173074 blocks H-510 and H-69 SCLC proliferation and clonogenic growth in …

… ), an inhibitor of the epidermal growth factor receptor, to patients with recurrent NSCLC. … as
a prognostic factor, whether basic fibroblast growth factor is a favorable prognostic factor, and …

… Growth factor deprivation was achieved by culture of BEAS-2B cells for 6 days in LHC-9
medium without added growth factors or hormones. Acute NNK exposure was for 24 h at a …

… growth factor receptor (EGFR) is occasionally amplified and/or mutated in non–small cell lung
cancer (… We therefore investigated lung cancer cell lines for alterations in EGFR gene copy …

… Growth Factor Receptor). The EGFR family is a group of four structurally similar growth factor
… , including EGF (Epidermal Growth Factor) and TGF (Transforming Growth Factor), allowing …

… A year has passed since mutations of the tyrosine kinase domain of the epidermal growth
factor receptor (EGFR) were discovered in patients with non–small cell lung cancer (NSCLC) …

… growth factors and of their specific receptors has been performed … Several peptide growth
factors that are locally … the EGF-bike growth factors, also regulate cancer development …

Purpose Gefitinib and erlotinib are small molecules that selectively inhibit epidermal growth
factor receptor (EGFR) tyrosine kinase activity. When these drugs were introduced into the …

… The epidermal growth factor receptor (EGFR) and its ligand transforming growth factor (TGF)
alpha are hypothesized to form an autocrine growth loop in non-small cell lung cancer (…

… on survival of patients with non-small cell lung cancer (NSCLC) and small cell lung
cancer (SCLC). However, VEGFC and vascular endothelial growth factor receptor 3 (VEGFR3)/flt-1 …